RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
  AIDS
  Anthrax
  Dengue
  Ebola
  HCV
  Influenza
  Leishmaniasis
  Malaria
  MRSA
  Mumps
  Pertussis
  Prion Diseases
  SARS
  Shigella
  Small Pox
  Tuberculosis
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Infectious Diseases Channel

subscribe to Infectious Diseases newsletter
Latest Research : Infectious Diseases

   EMAIL   |   PRINT
Flagging the Remnants of a Fatal Infection

Apr 27, 2005 - 2:27:00 AM
Before dendritic cells can sound the immune alarm, they must capture antigens, chop them into peptide fragments, and bind the antigenic peptides to molecules of the major histocompatibility complex (MHC). Though dendritic cells can present to helper or killer T cells, it had been thought that the MHC I–bound antigens (recognized by killer T cells) must first enter the dendritic cell’s cytosol and undergo proteasome degradation.

 
[RxPG] For a cell, suicide is a perfectly acceptable response to stress. Programmed cell death, or apoptosis, is a normal part of development: it occurs 131 times over the course of worm development, for example, and throughout the life of an organism to replenish worn out cells in a variety of tissues. Disease and infection also trigger apoptosis. The dying cell shrinks into a membrane-bound package that attracts the attention of phagocytes, which quickly ingest and degrade the cell’s contents. Dendritic cells, specialized phagocytes, patrol the body, capturing molecules (or antigens) expressed by a host of pathogens, parasites, environmental substances, and apoptotic cells, and present their findings to the helper and killer T cells that launch an immune response.

Before dendritic cells can sound the immune alarm, they must capture antigens, chop them into peptide fragments, and bind the antigenic peptides to molecules of the major histocompatibility complex (MHC). Though dendritic cells can present to helper or killer T cells, it had been thought that the MHC I–bound antigens (recognized by killer T cells) must first enter the dendritic cell’s cytosol and undergo proteasome degradation. It was also thought that antigenic peptides needed the transporter activity of TAP (transporter associated with antigen processing) proteins to escort them into the cellular compartment where the MHC I molecules reside.

A new study by Nathalie Blachère, Robert Darnell, and Matthew Albert lends support to an emerging view that antigen processing may be more flexible and suggests that dendritic cells can generate MHC I peptides that activate killer T cells through cross-presentation. (The phenomenon is called cross-presentation because the pathway crosses established rules of MHC I antigen presentation.) Working with a mouse model to study killer T cell activation in response to influenza antigens derived from apoptotic cells, the authors show that two distinct pathways mediate antigen processing. In the first pathway, antigen processing in dendritic cells depends on TAP, following the established model. But in the second pathway, antigens processed by a dying, infected cell can bypass the dendritic cells’ degradation machinery yet still permit generation of MHC I/peptide complexes that can engage killer T cells.

T cells can recognize millions of different antigens because each T cell is outfitted with a unique T cell antigen receptor that recognizes a unique MHC/peptide complex. In this study, the authors used the activation of influenza-reactive T cells as evidence of antigen presentation. To test the hypothesis that dying cells can process antigen for cross-presentation, Blachère et al. limited the dendritic cells’ ability to process antigen by using cells extracted from the bone marrow of mice lacking functional TAP proteins. If the cells could provoke a T cell response, then antigen-specific MHC I/peptide complexes would have to arise through an alternate pathway.

When TAP-deficient dendritic cells were directly infected with influenza, they could not elicit a T cell response. But when infected dying cells were internalized by the TAP-deficient dendritic cells, the dendritic cells were able to cross-present influenza antigen and activate the T cells. To investigate the mechanism of cross-presentation, the authors generated cells with deficient proteasomes that could not degrade viral proteins, and also used another cell line inhibited in TAP activity. When either of these cell types were infected with influenza, caused to undergo apoptosis, and engulfed by dendritic cells, it became clear that the dendritic cells needed functional TAP to successfully present the influenza antigen to T cells. The authors then went on to validate the operation of these pathways in vivo.

Altogether, these results point to two MHC I pathways: one relies on transporter activity in the dendritic cell; the other allows dendritic cells to capture antigens already processed in the dying cell. Though the details of the cross-presentation pathway remain unclear, the conditions that give rise to it are not: when dendritic cells are directly infected, they mediate antigen processing. When dendritic cells ingest already infected, apoptotic cells, the dying cells deliver processed antigen and set the stage for cross-presentation. It’s possible that stressful conditions, like an influenza infection, trigger this cross-presentation pathway, allowing the dying cell to alert the immune system to a pathogenic agent that requires immediate action.



Publication: (2005) A Dying Cell’s Last Hurrah: Flagging the Remnants of a Fatal Infection. PLoS Biol 3(6): e197
On the web: Print PDF (35K) 

Advertise in this space for $10 per month. Contact us today.


Related Infectious Diseases News
4 UCLA stem cell researchers receive CIRM Early Translational grants
Professor Vanessa Hayes awarded for exceptional Africa-related work
Plant-based compound may inhibit HIV
Innovative intervention program improves life for rural women in India living with HIV/AIDS
The American Society for Microbiology honors Baligh Yehia
Thomas J. Coates receives 2013 Elizabeth Fries Health Education Award
Scientists find ethnicity linked to antibodies
2013 Canada Gairdner Global Health Award goes to King Holmes for STD work
Study identifies ways to increase HIV testing, reduce HIV infection
A device to speed up HIV diagnostic test

Subscribe to Infectious Diseases Newsletter

Enter your email address:


 Additional information about the news article
A Dying Cell’s Last Hurrah: Flagging the Remnants of a Fatal Infection

DOI: 10.1371/journal.pbio.0030197

Published: April 26, 2005

Copyright: © 2005 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)